(Q40607649)
Statements
1 reference
Phase I pilot trial of the bispecific antibody MDXH210 (anti-Fc gamma RI X anti-HER-2/neu) in patients whose prostate cancer overexpresses HER-2/neu (English)
1 reference
Schwaab T
1 reference
Lewis LD
1 reference
Cole BF
1 reference
Deo Y
1 reference
Fanger MW
1 reference
Wallace P
1 reference
Guyre PM
1 reference
Kaufman PA
1 reference
Heaney JA
1 reference
Schned AR
1 reference
Harris RD
1 reference
Ernstoff MS
1 reference
1 January 2001
1 reference
1 reference
24
1 reference
1
1 reference
79-87
1 reference
Identifiers
1 reference
1 reference